BMJ Group Retina Logo
BMJ Group Retina Logo
Find an expert2024-06-07T09:48:34+00:00

Find an expert

Our panel of editors are available for interview

Filters
Expertise

Dr James Mountford

2024-06-27T15:57:33+00:00Expertise : , , , , |

Editor-in-Chief of BMJ Leader

Contact

Dr James Mountford is Director of Quality at Royal Free London NHS Foundation Trust. He worked initially as an NHS doctor, then in consulting. From 2005-2007, he was a Commonwealth Fund Health Foundation Harkness Fellow based in Massachusetts General Hospital, and at the Institute for Healthcare Improvement (IHI), both in Boston, USA. Before moving to the Royal Free, he was Director of Quality at UCL Partners, an academic health sciences partnership serving a population of 3 million in and around London. He sits on the board of AQuA, the improvement partnership based in north-west England. In March 2020 he was seconded to work as the Chief of Quality and Learning at the NHS Nightingale Hospital London, opened in response to the COVID-19 pandemic.

Shanti Raman

2024-06-27T16:02:16+00:00Expertise : , , |

Editor-in-Chief of BMJ Paediatrics Open

Contact

Shanti Raman is a Consultant Paediatrician, with sub-specialty training in Community Child Health, epidemiology and public health. She is the Director of Community Paediatrics – South Western
Sydney, where she is responsible for clinical services in Child Development and Child Protection across the region, providing academic leadership and directing research and training. Her research
and teaching interests include health of migrants and refugees, indigenous child health, child rights and child maltreatment, quality and safety in health, global maternal, newborn and child health.

Professor Ronald F. van Vollenhoven

2024-06-27T16:03:26+00:00Expertise : , , |

Editor-in-Chief of Lupus Science & Medicine

Contact

Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.

Professor Anna Maria Geretti

2024-06-27T15:40:15+00:00Expertise : , , , , , , , |

Editor-in-Chief of Sexually Transmitted Infections

Contact

Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases at the Institute of Infection & Global Health of the University of Liverpool, and Honorary Consultant at the Royal Liverpool University Hospital. She trained in Italy, the Netherlands and the UK and has a special interest in HIV, hepatitis B and hepatitis C infection. She has published over 100 peer-reviewed articles, editorials, reviews and book chapters, runs capacity building programmes for resource-limited countries and enthusiastically shares her expertise to train doctors and scientists.

Professor John McMillan

2024-06-27T15:46:16+00:00Expertise : , |

Editor-in-Chief of the Journal of Medical Ethics

Contact

Professor John McMillan is a professor for the Bioethics Centre at the University of Otago. He is a member of the Advisory Committee for Assisted Reproductive Technology and the National Screening Advisory Committee, and has published broadly within bioethics.

Professor Hans Kromhout

2024-06-27T15:45:28+00:00Expertise : , , , , |

Editor-in-Chief of Occupational & Environmental Medicine

Contact

Professor Hans Kromhout is an occupational hygiene and epidemiology specialist, based at the Institute for Risk Assessment Sciences at Utrecht University in the Netherlands. Professor Kromhout’s work has covered the health effects of chemical and physical (EMF) agents in the workplace and general environment. He has been the (co-)PI of large international studies in among others the asphalt industry, rubber manufacturing industry, industrial minerals industry, health sector and agriculture and community based studies on cancer, respiratory diseases, neurodegenerative diseases and reproductive health effects.

Go to Top